Citi Reiterates Hold Rating on Healthcare Realty Trust with $17.00 Price Target

Citi analyst maintains a Hold rating on Healthcare Realty Trust with a price target of $17.00, while the analyst consensus is also a Hold with a price target of $16.94, representing a 1.26% upside from current levels. The company's shares closed yesterday at $16.73, and insider sentiment is positive with 46 insiders buying shares in the past quarter.

Healthcare Realty Trust Incorporated (NYSE: HR) continues to face a mixed sentiment from analysts, with a majority maintaining a Hold rating despite a slight upward adjustment in price targets. Citi analyst, for instance, has maintained a Hold rating with a price target of $17.00, while the analyst consensus remains at a Hold with a price target of $16.94, representing a 1.26% upside from current levels [1].

The company's shares closed yesterday at $16.73, indicating a relatively stable performance. However, insider sentiment has been positive, with 46 insiders buying shares in the past quarter. This positive insider activity can be seen as a vote of confidence in the company's future prospects [1].

Healthcare Realty Trust has recently experienced a series of changes in its dividend and stock recommendations. The company cut its dividend to $0.24 per share, resulting in a dividend yield of 5.8% and a negative payout ratio of -107.83% [1]. Despite this, the company's shares have shown resilience, trading within a range of $14.09 to $18.90 over the past 12 months [1].

Several analysts have also provided their insights on the company's stock. Wells Fargo & Company, for example, reduced its target price from $16.00 to $15.00 and set an "underweight" rating, while Wedbush lowered its target price from $18.00 to $16.00 and set a "neutral" rating [1]. Wall Street Zen, on the other hand, downgraded the stock from a "hold" to a "sell" rating [1].

Institutional investors have also shown interest in the company, with several institutions increasing their stakes in Healthcare Realty Trust. Starboard Value LP, for instance, bought a new position worth $342.11 million in the 4th quarter, while Massachusetts Financial Services Co. MA bought a new position worth $100.82 million in the 1st quarter [1].

Overall, while the analyst consensus remains neutral, the positive insider sentiment and recent institutional investments could signal potential upside for Healthcare Realty Trust. However, investors should closely monitor the company's financial performance and any changes in analyst recommendations.

References:
[1] https://www.marketbeat.com/instant-alerts/healthcare-realty-trust-incorporated-nysehr-receives-average-recommendation-of-reduce-from-brokerages-2025-08-11/